A single drop of blood

Know your brain before
it forgets you.

Gentle, early, at-home screening backed by multi-omic AI — helping you and the people you love stay ahead of Alzheimer's and dementia.

Check your risk For clinicians
How it works
From one blood draw to early insight

PathoBrainSeq reads the molecular signals your blood carries — combining genomic and single-cell immune profiling with AI to surface neurodegenerative risk earlier than symptom-based screening. Research-stage.

1
A single blood draw
No spinal taps, no scans. Just one routine sample.
2
Multi-omic AI analysis
Genome- and immune-level signals read together by our models.
3
A clear risk picture
An interpretable risk summary for you and your clinician.
Our platform
Three ways we help
mNeuroMap™
Simple cognitive screening you can do at home, on your phone.
Get it on the App Store →
NeuroMapDx™
Clinical AI that gives clinicians a 360° view to decide with confidence.
Request blood analysis →
cMindMap™
A shared, gentle space for families to keep memories alive together.
Visit cMindMap →
Roadmap
What we can assess today

We only build what the data supports. Our models are validated for the conditions below — and we expand carefully as new cohorts grow.

Alzheimer's diseaseAvailable
DementiaAvailable
Parkinson's & other neurodegenerative conditionsAs data grows
For clinicians & researchers
Request a blood analysis

Submit an inquiry to run a sample through NeuroMapDx™. Our team will follow up with next steps and a request form.